Roble Belko & Company’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $29K | Hold |
71
| – | – | ﹤0.01% | 211 |
|
2025
Q1 | $35K | Hold |
71
| – | – | 0.01% | 190 |
|
2024
Q4 | $37K | Hold |
71
| – | – | 0.01% | 186 |
|
2024
Q3 | $44K | Hold |
71
| – | – | 0.01% | 170 |
|
2024
Q2 | $39K | Hold |
71
| – | – | 0.01% | 178 |
|
2024
Q1 | $41K | Sell |
71
-50
| -41% | -$28.9K | 0.01% | 183 |
|
2023
Q4 | $64K | Hold |
121
| – | – | 0.01% | 150 |
|
2023
Q3 | $61K | Hold |
121
| – | – | 0.01% | 141 |
|
2023
Q2 | $63K | Hold |
121
| – | – | 0.01% | 133 |
|
2023
Q1 | $70K | Hold |
121
| – | – | 0.01% | 139 |
|
2022
Q4 | $67K | Hold |
121
| – | – | 0.01% | 143 |
|
2022
Q3 | $61K | Hold |
121
| – | – | 0.01% | 144 |
|
2022
Q2 | $66K | Sell |
121
-22
| -15% | -$12K | 0.02% | 139 |
|
2022
Q1 | $84K | Buy |
143
+72
| +101% | +$42.3K | 0.02% | 142 |
|
2021
Q4 | $47K | Hold |
71
| – | – | 0.01% | 164 |
|
2021
Q3 | $41K | Hold |
71
| – | – | 0.01% | 158 |
|
2021
Q2 | $36K | Hold |
71
| – | – | 0.01% | 175 |
|
2021
Q1 | $32K | Buy |
71
+64
| +914% | +$28.8K | 0.01% | 173 |
|
2020
Q4 | $3K | Hold |
7
| – | – | ﹤0.01% | 279 |
|
2020
Q3 | $3K | Buy |
+7
| New | +$3K | ﹤0.01% | 282 |
|